Amerika Serikat - Inggris - NLM (National Library of Medicine)

ranbaxy laboratories inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - tablet, coated - 120 mg - isoptin sr (verapamil hci) is indicated for the management of essential hypertension. verapamil hci is contraindicated in: 1. severe left ventricular dysfunction (see warnings) 2. hypotension (systolic pressure less than 90 mmhg) or cardiogenic shock 3. sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker) 4. second- or third-degree av block (except in patients with a functioning artificial ventricular pacemaker). 5. patients with atrial flutter or atrial fibrillation and an accessory bypass tract (e.g., wolff-parkinson-white, lown-ganong-levine syndromes). (see warnings). 6. patients with known hypersensitivity to verapamil hydrochloride.

Singapura - Inggris - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - verapamil hydrochloride - tablet, film coated - 240 mg - verapamil hydrochloride 240.0 mg

Kanada - Inggris - Health Canada

bgp pharma ulc - verapamil hydrochloride - tablet (extended-release) - 240mg - verapamil hydrochloride 240mg - miscellaneous calcium-channel blocking agents

Malaysia - Inggris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbott laboratories (m) sdn. bhd. - verapamil hydrochloride -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 180 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; sodium alginate; povidone; magnesium stearate; hypromellose; macrogol 400; macrogol 6000; purified talc; glycol/butylene glycol montanate; titanium dioxide; iron oxide red - modified release tablets,isoptin sr is indicated for the management of hypertension and angina pectoris.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

viatris limited - verapamil hydrochloride 120mg - modified release tablet - 120 mg - active: verapamil hydrochloride 120mg excipient: glycol montanate hypromellose macrogol 400 macrogol 6000 magnesium stearate microcrystalline cellulose povidone purified talc purified water sodium alginate titanium dioxide - · angina pectoris - for the prophylaxis and treatment of coronary insufficiency: chronic stable angina pectoris; angina at rest including vasospastic (prinzmetal's, variant angina) and unstable angina (crescendo, pre-infarction angina); angina pectoris post myocardial infarction.

Arab Saudi - Inggris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

abbott laboratories, germany - verapamil hydrochloride - prolonged-release tablet - 120 mg

Arab Saudi - Inggris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

abbott laboratories, germany - verapamil hydrochloride - prolonged-release tablet - 240 mg

Afrika Selatan - Inggris - South African Health Products Regulatory Authority (SAHPRA)

abbott laboratories s.a. (pty) ltd - tablet - 240,0 mg - each tablet contains verapamil 240,0 mg

Uni Emirat Arab - Inggris - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

gulf drug llc united arab emirates - 20 's(10's blister x 2) - tablet - 240mg / tablet - cardiovascular system-nitrates , calcium-channel blockers